Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19372511.
- Also identified by DOI 10.2105/AJPH.2008.141846 and PMC identifier 2679784.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HIV-prevention measures specific to injection drug users (IDUs), such as opioid substitution treatment and needle-and-syringe programs, are not provided in many countries where injection drug use is endemic. We describe the incidence of diagnosed HIV infection in IDUs and the availability and coverage of opioid substitution and needle-and-syringe programs in the European Union and 5 middle- and high-income countries. Countries with greater provision of both prevention measures in 2000 to 2004 had lower incidence of diagnosed HIV infection in 2005 and 2006.
Medical subject headings
- Drug Users
- HIV Infections
- Health Services Accessibility
- Preventive Health Services
- Substance Abuse, Intravenous